BioXcel Therapeutics (BTAI)
(Delayed Data from NSDQ)
$2.71 USD
-0.26 (-8.75%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.71 0.00 (0.00%) 7:00 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.69 |
EPS Last Quarter | -0.76 |
Last EPS Surprise | 22.45% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.39 |
Next Year | -1.85 |
EPS (TTM) | -6.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.42M | 0.55M | 3.75M | 10.80M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 0.42M | 0.55M | 5.00M | 11.60M |
Low Estimate | 0.42M | 0.55M | 2.49M | 10.00M |
Year ago Sales | 0.21M | 0.46M | 1.38M | 3.75M |
Year over Year Growth Est. | 100.00% | 19.57% | 171.38% | 188.38% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.69 | -0.63 | -2.39 | -1.85 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.69 | -0.63 | -2.42 | -1.61 |
High Estimate | -0.69 | -0.63 | -2.36 | -1.61 |
Low Estimate | -0.69 | -0.63 | -2.42 | -2.08 |
Year ago EPS | -1.84 | -1.83 | -6.15 | -2.39 |
Year over Year Growth Est. | 62.50% | 65.57% | 61.14% | 22.80% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.69 | -0.63 | -2.39 | -1.85 |
7 Days Ago | -0.68 | -0.63 | -2.46 | -1.85 |
30 Days Ago | -0.75 | -0.55 | -2.29 | -1.66 |
60 Days Ago | -1.04 | -0.78 | -2.44 | -1.72 |
90 Days Ago | -1.04 | -0.78 | -2.24 | -1.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.63 | -2.42 | -1.61 |
Zacks Consensus Estimate | -0.69 | -0.63 | -2.39 | -1.85 |
Earnings ESP | 0.00% | 0.00% | -1.26% | 12.74% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.76 | -1.72 | -1.83 | -1.84 | NA |
Estimate | -0.98 | -1.29 | -1.72 | -1.56 | NA |
Difference | 0.22 | -0.43 | -0.11 | -0.28 | -0.15 |
Surprise | 22.45% | -33.33% | -6.40% | -17.95% | -8.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more